Introduced:
Sep 10, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Sep 10, 2025
Read twice and referred to the Committee on Finance.
Actions (2)
Read twice and referred to the Committee on Finance.
Type: IntroReferral
| Source: Senate
Sep 10, 2025
Introduced in Senate
Type: IntroReferral
| Source: Library of Congress
| Code: 10000
Sep 10, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(D-MI)
Sep 10, 2025
Sep 10, 2025
Full Bill Text
Length: 6,694 characters
Version: Introduced in Senate
Version Date: Sep 10, 2025
Last Updated: Nov 15, 2025 2:12 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2760 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 2760
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 10, 2025
Ms. Murkowski (for herself and Ms. Slotkin) introduced the following
bill; which was read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[S. 2760 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 2760
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 10, 2025
Ms. Murkowski (for herself and Ms. Slotkin) introduced the following
bill; which was read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide hereditary
cancer genetic testing for individuals with a history of a hereditary
cancer gene mutation in a blood relative or a personal or ancestral
history suspicious for hereditary cancer, and to provide coverage of
certain cancer screenings or preventive surgeries that would reduce the
risk for individuals with a germline
(inherited) mutation associated
with a high risk of developing a preventable cancer.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Reducing Hereditary Cancer Act of
2025''.
SEC. 2.
HISTORY OF A HEREDITARY CANCER GENE MUTATION OR PERSONAL
OR FAMILY HISTORY SUSPICIOUS FOR HEREDITARY CANCER.
(a) Coverage.--
OR FAMILY HISTORY SUSPICIOUS FOR HEREDITARY CANCER.
(a) Coverage.--
Section 1861 of the Social Security Act (42 U.
1395x) is amended--
(1) in subsection
(s)
(2) --
(A) in subparagraph
(JJ) , by inserting ``and'' at
the end; and
(B) by adding at the end the following new
subparagraph:
``
(KK) in the case of an individual with a personal or
family history of a hereditary cancer gene mutation or a
personal or family history suspicious for hereditary cancer,
germline mutation testing;''; and
(2) by adding at the end the following new subsection:
``
(nnn) Germline Mutation Testing.--The term `germline mutation
testing' means genetic testing for germline mutations that is in
accordance with evidence-based, clinical practice guidelines
specifically addressing genetic testing, screening, and management of
individuals with inherited mutations associated with increased cancer
risk that--
``
(1) have been developed by a nationally recognized
oncology professional organization, including the National
Comprehensive Cancer Network, the American Society of Clinical
Oncology, the Society of Gynecologic Oncology, or any other
oncology professional organization specified by a medicare
administrative contractor with a contract under
(1) in subsection
(s)
(2) --
(A) in subparagraph
(JJ) , by inserting ``and'' at
the end; and
(B) by adding at the end the following new
subparagraph:
``
(KK) in the case of an individual with a personal or
family history of a hereditary cancer gene mutation or a
personal or family history suspicious for hereditary cancer,
germline mutation testing;''; and
(2) by adding at the end the following new subsection:
``
(nnn) Germline Mutation Testing.--The term `germline mutation
testing' means genetic testing for germline mutations that is in
accordance with evidence-based, clinical practice guidelines
specifically addressing genetic testing, screening, and management of
individuals with inherited mutations associated with increased cancer
risk that--
``
(1) have been developed by a nationally recognized
oncology professional organization, including the National
Comprehensive Cancer Network, the American Society of Clinical
Oncology, the Society of Gynecologic Oncology, or any other
oncology professional organization specified by a medicare
administrative contractor with a contract under
section 1874A;
and
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, are the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.
and
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, are the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.''.
(b) Frequency.--
``
(2) in the case of conflicting guidelines developed by
more than one nationally recognized oncology professional
organization, are the least restrictive of such guidelines, as
determined by such a medicare administrative contractor.''.
(b) Frequency.--
Section 1862
(a)
(1) of the Social Security Act (42
U.
(a)
(1) of the Social Security Act (42
U.S.C. 1395y
(a)
(1) ) is amended--
(1) by striking ``and'' at the end of subparagraph
(O) ;
(2) by adding ``and'' at the end of subparagraph
(P) ; and
(3) by adding at the end the following new subparagraph:
``
(Q) in the case of germline mutation testing as defined
in
section 1861
(nnn) , which is performed more than once with
respect to an individual described in such section;''.
(nnn) , which is performed more than once with
respect to an individual described in such section;''.
(c) Effective Date.--The amendments made by this section shall
apply to testing furnished on or after the date of the enactment of
this Act.
SEC. 3.
(a) In General.--
Section 1862 of the Social Security Act (42 U.
1395y) is amended by adding at the end the following new subsection:
``
(p) Coverage of Certain Risk-Reducing Surgeries.--In the case of
an individual described in
``
(p) Coverage of Certain Risk-Reducing Surgeries.--In the case of
an individual described in
section 1861
(s)
(2) (KK) for whom, based on
evidence-based, clinical practice guidelines described in
(s)
(2) (KK) for whom, based on
evidence-based, clinical practice guidelines described in
section 1861
(nnn) , surgery would reduce the risk of developing cancer, such
risk-reducing surgery shall be considered reasonable and necessary for
treatment of illness under subsection
(a)
(1)
(A) .
(nnn) , surgery would reduce the risk of developing cancer, such
risk-reducing surgery shall be considered reasonable and necessary for
treatment of illness under subsection
(a)
(1)
(A) .''.
(b) Effective Date.--The amendment made by subsection
(a) shall
apply to items and services furnished on or after the date of the
enactment of this Act.
SEC. 4.
HEREDITARY CANCER GENE MUTATION.
(a) In General.--
(a) In General.--
Section 1862 of the Social Security Act (42 U.
1395y), as amended by
section 3, is amended by adding at the end the
following new subsection:
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.
following new subsection:
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.--In the case of an individual who is
determined pursuant to genetic testing to have a hereditary cancer
(germline) gene mutation, the Secretary shall increase any frequency
limitations (or other limitations on coverage otherwise applicable
under this title) for any evidence-based screenings furnished to such
individual, to be in compliance with evidence-based, clinical practice
guidelines described in
``
(q) Coverage of Evidence-Based Screenings for Individuals With a
Hereditary Cancer Gene Mutation.--In the case of an individual who is
determined pursuant to genetic testing to have a hereditary cancer
(germline) gene mutation, the Secretary shall increase any frequency
limitations (or other limitations on coverage otherwise applicable
under this title) for any evidence-based screenings furnished to such
individual, to be in compliance with evidence-based, clinical practice
guidelines described in
section 1861
(nnn) , or as determined appropriate
by the Secretary, but not less frequently than on an annual basis.
(nnn) , or as determined appropriate
by the Secretary, but not less frequently than on an annual basis. For
the purposes of this subsection, evidence-based screenings shall
include screening mammography, breast screening MRI, colonoscopy, PSA
testing, and any additional evidence-based screening modalities
appropriate for high-risk individuals as recommended by such
guidelines.''.
(b) Conforming Amendment for Screening Mammography.--
Section 1834
(c) (2)
(A) of the Social Security Act (42 U.
(c) (2)
(A) of the Social Security Act (42 U.S.C. 1395m
(c) (2)
(A) ) is
amended, in the matter preceding clause
(i) , by striking ``subparagraph
(B) '' and inserting ``subparagraph
(B) and
(A) of the Social Security Act (42 U.S.C. 1395m
(c) (2)
(A) ) is
amended, in the matter preceding clause
(i) , by striking ``subparagraph
(B) '' and inserting ``subparagraph
(B) and
section 1862
(q) ''.
(q) ''.
(c) Effective Date.--The amendments made by this section shall
apply to items and services furnished on or after the date of the
enactment of this Act.
<all>